Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
ABACAVIR LAMIVUDIN Mepha Lactab 600/300mg 30 Stk
Drug
Abacavir-Lamivudin-Mepha, Filmtabletten
HIV-Infektion
08.03.0. – antivirals
HAM – Human medicine
FILM – Film-coated tablet
S – synthetic products for human use
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
7/4/2018
12/31/9999
Dosage strength
Abacavir-Lamivudin-Mepha 600 mg/300 mg, Filmtabletten
HIV-Infektion
01
Z – approved
Package
7680670640015
In trade from / since 7/4/2018
A/R – Authorised / referenced
30 tablet(s)
001
Z – approved
Declaration
Component
600 mg abacavirum
300 mg lamivudinum
300 mg lamivudinum
cellulosum microcristallinum
hydroxypropylcellulosum
carboxymethylamylum natricum A
magnesii stearas
hypromellosum
macrogolum 4000
polysorbatum 80
E 171
E 172 (flavum)
E 172 (rubrum)
3.276 mg natrium
hydroxypropylcellulosum
carboxymethylamylum natricum A
magnesii stearas
hypromellosum
macrogolum 4000
polysorbatum 80
E 171
E 172 (flavum)
E 172 (rubrum)
3.276 mg natrium
Spezialitätenliste***
SL
-
-
286.60
None
No
10%
Yes
Authorisation holder
7601001396685
Mepha Pharma AG
Kirschgartenstrasse 14
4051 Basel (BS)
Kirschgartenstrasse 14
4051 Basel (BS)
Date of revision of the text
4/29/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.